It is stable with reduced population growth, based mainly on the fact that the gap between births and deaths remained slightly positive (0.1%) during the 1980s (French National Institute for Statistics and Economics INSEE, 1990) . It is a relatively young population with only 13.3% of the residents aged 65 or over compared to 15% for the whole of France. Only 6% of residents are foreigners (INSEE 1990) . In this population, 46% live in the urban centre of Dijon, 19% live in smaller towns and 35% live in rural areas (INSEE 1990) . Registration includes all HM including NHL, diagnosed for the first time since 1 January 1980 for patients living in Côte-d'Or. Information is routinely obtained from pathologists, medical specialists, mostly haematologists and oncologists, and death certificates to ensure completeness. In 1989, the efficiency and precision of this registry were confirmed by state audit by the National Institute for Health and Medical Research (INSERM).
There were 451 NHL (nodal or extra-nodal) in people over 19 years of age recorded between 1 January 1980 and 31 December 1991, considered in this study. Chronic lymphocytic leukaemia (CLL), was not included because it is regarded and recorded by the registry as an independent disease. All NHL were histologically confirmed. The registry accurately records administrative, clinical and histological data. At the time of analysis (end of December 1994), vital status was known for more than 96% of cases, from information obtained from town hall officials in reply to written requests.
Studied Variables
Cases were classified according to patient's age at diagnosis or 65 and over), their sex, their place of residence (Dijon city, small towns or rural areas), their histological type according to the 'working formulation' 5 (i.e. low grade, intermediate grade, high grade, and unknown or uninterpretable grade), their period of diagnosis (i.e. 1980-1983, 1984-1987 or 1988-1991) and according to their place of treatment (University Hospital of Dijon or other hospitals).
Statistical Analysis
In order to calculate incidence rates, the description of the Côte-d'Or population was obtained from the 1975, 1982 and 1990 censuses, by one-year age groups and by sex through INSEE. Populations were calculated for each 4-year period of the study by linear interpolation between 1975-1982 and 1983-1990 , then by extrapolation. Incidence rates were standardized using Segi's world standard population. 10 Time trends in incidence rates were studied for the three 4-year periods using the hypothesis of a log linearity of rates with time fitting a least-square regression line. The estimated slope and its standard error were used to calculate a mean percentage of annual variation in incidence and its significance.
Crude survival rates were calculated using KaplanMeier's Method 11 and survival curves were compared using the Log-rank test. Relative survival rates, defined as the ratio of the observed survival rates and the expected survival rates derived from the French population life tables, were also calculated. A multivariate survival analysis was performed using Cox's Proportional Hazards Regression Model 12 starting with all variables at the first step and a proportional hazard regression model for excess mortality as defined by Estève et al. 13 in order to compensate for background mortality. In this latter model the observed mortality rate is written as the sum of the mortality rate from lymphomas and that from causes as given by the French life table of 1985. Relative risks of death defining the main prognosis factors are calculated with these two models. The analysis was carried out using BMDP's software 'PC.90' (CA,USA) 14 and the Relsurv 1.0 program for relative survival (Hedelin, Strasbourg, France).
RESULTS

Incidence
Details of number of cases, age-standardized incidence by age at diagnosis, by place of residence and by histological grade classification respectively for males and females, as well as the sex ratio are given in Table 1 . NHL were more common among males (sex ratio of 1.31), in those over 64 years of age and for those living in Dijon. Considering the histological grade classification, the highest incidence rates were represented by the intermediate-grade NHL for males but by the low-grade NHL for females. The sex ratio shows the predominance of males, except in the small towns where crude incidence rates of NHL were the same for males and females. Only two patients with AIDS-related lymphomas were recorded during the 12-year period, one in 1989 and one in 1991.
Time Trend Incidence
Incidences for period of diagnosis by sex, age at diagnosis, place of residence and histological grade classification are given in Table 2 . The mean annual age-standardized incidence rate was 6.5 per 100 000 in males and 4.0 per 100 000 in females. Incidence rates increased regularly throughout the three 4-year periods. NHL incidence has increased significantly more for males than females, further widening the gap in incidence between the sexes. The incidence of unknown or non-interpretable grade decreased between 1980 and 1991. High-grade lymphomas were the least common NHL up to 1987 but by 1988 they had become more common than intermediate-grade lymphomas; lowgrade NHL were the most frequent from 1988 on. Mean annual increase in the incidence rate over the period studied was slightly greater for younger than for older patients, for people living in rural areas compared to people living in urban areas and for high-grade NHL compared to low-and intermediate-grade NHL.
Survival Follow-up A total of 281 cases died during follow-up; 14 cases were lost to follow-up; mean follow-up time was 50.0 months (standard deviation 43.2).
Survival of Patients with NHL
The 5-year crude survival rate for all NHL was 47.4% (standard error [SE] 9.6%). The corresponding relative survival rate was 69.3% (SE 9.5%). The one-and 5-year crude and relative survival rates, according to the different variables taken into account in the analysis, are given in Table 3 . There was no significant difference in prognosis by sex; 59.6% (SE 3.8) and 66.9% (SE 4.1) of males and females respectively were alive after 5 years according to the relative survival analysis. When considering crude survival rates, 'age' was a significant factor; patients older than 64 had a lower survival curve than younger patients (P Ͻ 0.001). For 'Age' relative survival rates were 64.3 (SE 3.7) and 53.3 (SE 4.1) respectively for people younger or older than 65 (P Ͻ 0.05). Comparing crude survival curves, patients living in urban areas survived longer than patients living in rural areas (P Ͻ 0.01). The histological grade was an important determinant of prognosis; survival rates decreasing dramatically from low-grade to high-grade (P Ͻ 0.001). Relative survival curves by histological grades are given in Figure 1 . The percentage of survivors according to the relative survival analysis decreasing from 78.6 (SE 4.9) to 36.8 (SE 5.2) respectively for low and high grades. Prognosis was not significantly related to the place of treatment, or to the period of diagnosis. 
Prognostic Factors for NHL
The six variables taken into account in the univariate analysis were analysed using Cox's model (Table 4) . The relative risk of death for patients over 64 was 1.9 compared to younger patients. For patients living in a rural area, the relative risk of death was 1.63 compared to patients living in urban areas and for patients having high-grade NHL compared to those having a low-grade tumour the RR was 2.23. Sex, place of hospitalization, and study period have no significant impact on prognosis. The relative risk of death for all NHL has not changed significantly over the three time periods considered. Using Estève's relative survival model, place of residence and histological grade were the only two criteria independently related to survival (Table 4) . Age was no longer seen to be a significant prognostic factor. As with the Cox model neither sex, place of treatment nor period of diagnosis were significant prognostic factors.
DISCUSSION
These data confirm the significant increase in incidence of NHL since the beginning of the 1980s. Mortality data from the 1968-1987 period had already demonstrated an increase in mortality rates in most industrialized countries, particularly in the US, Japan, West Germany, England and Wales, Italy and France. 15 For the 1950-1985 period, the increase in mortality rates in France was estimated to be 2.4% and 2.7% per year respectively for men and women, a figure slightly lower than the reported increase in incidence. 16 Such data on mortality are nevertheless subject to bias, including changes in survival rates, in classification but especially with respect to the quality of death certification. 17, 18 Our findings suggest these values to be grossly underestimated.
This study has the advantage of including all cases of NHL diagnosed in a well-defined French population, thus avoiding selection bias. The cancer registry of the Doubs, an area adjacent to Côte-d'Or, reported agestandardized incidence rates similar to ours (6.7 for males and 4.6 for females) in the 1983-1987 period. 2 Increases in mean incidence rates were found between the fifth (1982) (1983) (1984) (1985) (1986) ) and the sixth (1987) (1988) (1989) (1990) (1991) volumes of Cancer Incidence in Five Continents, 19 , 2 in several western European countries. US data demonstrated a noteable increase in incidence over the 1973-1987 period. 7 This could partly be explained by improvements in diagnosis, and by the increasing number of AIDS-related lymphomas. 20 In the Côte-d'Or registry only two cases with AIDS-related lymphomas were found, which could not be the aetiologic cause of this dramatic and worrying increase in NHL. A Swedish (France 1980 (France -1991 study proposed the secular increase in exposure to ultraviolet light as a possible explanation for the increased incidence of NHL in recent decades. 21, 22 Although one must keep in mind that a better registration process could be a possible explanation for the increase in incidence between the first and the latter periods. This is unlikely in our study, seeing that the numbers of the other HM have remained stable according to the Côte-d'Or registry. Furthermore the number of NHL seems to have remained stable between 1989 and 1992, but these findings must be investigated in more detail in order to be confirmed.
In a public health context, it is also of interest to know the survival of cancer patients in relation to mortality for the whole area. [23] [24] [25] Through adjusted survival rates, the real effect of the prognostic variables, whether by crude survival rates or even the multivariate survival method, can be more conclusively proven. Using the recent model of relative survival proposed by Estève et al. 13 estimation of survival rates and relative risk of death are calculated, taking into account all the other causes of death in the analysed population. Since our survival data were almost exhaustive, with a complete follow-up rate of 96% and with the advantages of a specialized registry, the survival analysis took into account more prognostic factors than did previous international studies.
However, the Ann Arbor's clinical classification, which was provided in the registry datafile was not taken into account. Investigation methods changed in Dijon between 1980 and 1991: for example surgical investigations are now less common, having been replaced by computerized tomography which was introduced in the University Hospital of Dijon in 1985. If this form of clinical classification had been used in the study we might have introduced a stage migration bias, resulting from the evolution in diagnostic techniques, and thus in determination of clinical stages. 26 As the Working Formulation classification was created in 1982, the histological types were defined by reexamining the slides for cases initially recorded before its use. Difficulties associated with this retrodefinition (Burgundy, France 1980 -1991 Age was found to be a prognostic factor in the univariate analysis, when considering both crude and relative survival rates. Multivariate models are used to select variables which are independently related to the mortality hazard in the cohort. Age was still a significant prognostic factor in the Cox's model, but not so in the Estève's model. The crude multivariate survival model does not determine whether the effect of age is related to the disease itself, to natural mortality in the cohort or to both. The ideal situation would be to identify all causes of death and establish the net survival, i.e. to consider only deaths due to the disease. It is only feasible for small populations and diseases where it is easy to relate a given death to its cause. Relative multivariate survival models represent an alternative solution; the observed mortality rate being corrected by life expectancy. Age at diagnosis is no more a significant prognostic factor in the relative multivariate survival model, suggesting that most of the age effect was due to the differences in life expectancy between the age groups.
In this population-based series, as in other published series, the major prognostic factor for NHL was the histological grade classification. Small lymphocytic or plasmocytoid NHL, follicular, small cleaved cell NHL and follicular, mixed small cleaved and large cell NHL, which are in the same group according to the 'Working Formulation', i.e. low-grade lymphomas, have identical survival curves. 5 Their prognosis is much better than for high-grade NHL.
We also observed an important relationship between the place of residence and prognosis: patients living in rural areas had a twofold higher risk of dying during the follow-up period compared to patients living in urban areas. Although this difference could result from differences in the quality of treatment, this is unlikely, as the place of treatment does not affect survival. The most plausible hypothesis is that NHL are clinically more advanced at time of diagnosis in rural areas than in urban areas. This may reflect a lower availability of care in rural areas or lesser concern among these patients for their health.
Relative survival data from the SEER programme in the US show a significant improvement in survival rates when comparing the 1974-1976 period to the 1981-1987 period. 7 Data from the Swedish Cancer Registry show that 5-year survival rate improved markedly between the 1961-1963 and the 1987-1989 periods, but there has been no great improvement from the beginning of the 1980s to the end of this decade. 27 In the Swiss canton of Vaud, a non-significant increase in NHL survival was observed when comparing the 1974-1978 period and the 1979-1983 period. 28 In our study, covering a more recent period, no significant 5-year change in survival was found.
However, our conclusion is that the prognosis for NHL has not improved over the last two decades. The higher risk of death among people living in the country and the increased incidence in urban areas should both be investigated. Further research on the causes of this noteable increase in NHL incidence is essential.
